Robert Ćhilton

5.5k citations
125 papers · 2.9k · 1 hit paper · h-index 31

Impact in

Papers in

Robert Ćhilton

110 papers receiving 2.7k citations

Robert Ćhilton's Hit Papers

Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes 2015 · 379 citations
3790+3+7Years since publication100200300

Peers

Robert Ćhilton
Comparison fields: 5 of 122
  • Endocrinology, Diabetes and Metabolism 1.4k
  • Cardiology and Cardiovascular Medicine 600
  • Pharmacology 289
  • Clinical Biochemistry 105
  • Surgery 574
Replace Shui‐Ping Zhao with:
Shui‐Ping Zhao China
Daniele Versari Italy
Shinji Koba Japan
Enrique Z. Fisman Israel
Bernhard R. Winkelmann Germany
Lisa R. Tannock United States
Gaetano Vaudo Italy
Bruno Fabris Italy
Tjerk W.A. de Bruin Netherlands
Peter Fasching Austria
Robert Ćhilton relative to Shui‐Ping Zhao China Shui‐Ping Zhao's profile →
Citations per field
00.5×1.5×1.8×
Shui‐Ping Zhao · 1×
Citations per year

Countries citing papers authored by Robert Ćhilton

Since Specialization
Citations

This map shows the geographic impact of Robert Ćhilton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Ćhilton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Ćhilton more than expected).

Fields of papers citing papers by Robert Ćhilton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Ćhilton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Ćhilton. The network helps show where Robert Ćhilton may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert Ćhilton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert Ćhilton Line = papers co-authored together Robert Ćhilton links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes
Hit paper breakdown →
2015379
2 2016238
3 2015143
4 2010119
5 1981114
6 2017110
7 2018104
8 202079
9 201465
10 201058
11 201757
12 200355
13 201048
14 201646
15 201345
16 201942
17 200841
18 201440
19 201739
20 202138

About Robert Ćhilton

Robert Ćhilton is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Surgery, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 125 papers that have together received 2.9k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (49 papers), Metabolism, Diabetes, and Cancer (20 papers), Cardiovascular Function and Risk Factors (19 papers), Pancreatic function and diabetes (12 papers), Cardiac Imaging and Diagnostics (12 papers), Lipoproteins and Cardiovascular Health (11 papers), Diabetes Management and Research (10 papers) and Coronary Interventions and Diagnostics (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.4k citations), Cardiology and Cardiovascular Medicine (600 citations), Pharmacology (289 citations), Clinical Biochemistry (105 citations) and Surgery (574 citations). Robert Ćhilton has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Odd Erik Johansen, Stefano Del Prato, Ralph A. DeFronzo, Hans J. Woerle, Uli C. Broedl, Muhammad Abdul‐Ghani, S. Crowe, Christopher P. Cannon, I. Tikkanen and Rene Oliveros. Their work appears in journals such as Current Atherosclerosis Reports, Diabetes Obesity and Metabolism, The American Journal of Cardiology, Journal of the American College of Cardiology and Journal of Clinical Hypertension.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact